Laupacis, Andreas. “Evidence and Values: Requirements for Public Reimbursement of Drugs for Rare Diseases- A Case Study in Oncology- Reply”. Journal of Population Therapeutics and Clinical Pharmacology 16, no. 2 (December 8, 2018). Accessed October 10, 2025. https://www.jptcp.com/index.php/jptcp/article/view/557.